|Articles|April 1, 2001

April 2001
Volume 7
Issue 4

Impact of Poorly Controlled Hypertension on Healthcare Resource Utilization and Cost

Author(s)L. Clark Paramore, MSPH, Michael T. Halpern, MD, PhD, Pablo Lapuerta, MD

Download PDF: Impact of Poorly Controlled Hypertension on Healthcare Resource Utilization and Cost

Articles in this issue

over 25 years ago

Article

Indirect Cost of Ischemic Heart Disease to Employers

over 25 years ago

Article

Cost-Sharing for Prescriptions of Sildenafil and Finasteride: A Case Study in Veteran Patients

over 25 years ago

Article

Effects of Compensation Method on Physician Behaviors

over 25 years ago

Article

Healthy Pregnancy Program in a National Managed Care Organization: Evaluation of Satisfaction and Health Behavior Outcomes

over 25 years ago

Article

The Effect of Nonsteroidal anti-inflammatory Drugs on the Use of Gastroprotective Medication in People with Arthritis

over 25 years ago

Article

Achieving Control of Diabetic Risk Factors in Primary Care Settings

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Readability of Hospital Patient Financial Policy Documents

BySamantha Randall, BA,Sumedha Raghu, MS,Ella Cho,Nina Linh Nguyen, MHA,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

July 7th 2026

Impact of Poorly Controlled Hypertension on Healthcare Resource Utilization and Cost

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

AI Chatbots Score Below 28% on Colorectal Cancer Questions

FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma

5 Notable FDA Approvals From the First Half of 2026

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

INCA033989 May Address Unmet Need in Mutant Calreticulin Myelofibrosis: Claire Harrison, MD

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Impact of Poorly Controlled Hypertension on Healthcare Resource Utilization and Cost

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

AI Chatbots Score Below 28% on Colorectal Cancer Questions

FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma

5 Notable FDA Approvals From the First Half of 2026

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

INCA033989 May Address Unmet Need in Mutant Calreticulin Myelofibrosis: Claire Harrison, MD